Sep 7, 2025, 13:37
Unfractionated Heparin Dosing in ECMO: A Systematic Review and Meta-Analysis
RPTH Journal shared on LinkedIn:
”ECMO is life-saving technology!
What is better for patient outcomes? This review compares low dose vs standard unfractionated heparin on patient morbidity and mortality.”
Read the full article here.
Article: Mortality and Complications in Low-Dose versus Standard-Dose Unfractionated Heparin Anticoagulation for Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
Authors: Wincy Wing-Sze Ng, Rex Wan-Hin Hui, Ka-Chun Leung, Pauline Yeung Ng, Chun-Wai Ngai, Simon Wai-Ching Sin, Chun-Fung Sin
Stay updated on the latest scientific advances in the field of coagulation with Hemostasis Today.
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics